We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Maha Othman

Maha Othman MD, MSc, PhD

Associate Professor, Department of Biomedical and Molecular Sciences, School of Medicine, Queen's University, Kingston, Ontario, Canada

Dr. Maha Othman, MD, MSc, PhD, is a physician, scientist, educator, mentor, and leader with over 20 years of experience in healthcare, research and academia. She holds MBBCh and MSc in Clinical Pathology in Mansoura University, Egypt, and a PhD in Pathology from Southampton University, UK, with a specialization in haemostasis. She completed a post-doctoral research training in haemostasis at Queen’s University, Canada. Dr. Othman is a worldwide leader on the diagnosis and management of the bleeding disorder Platelet-type von Willebrand disease (PT-VWD) and an international advocate for improving hemostasis testing using thromboelastography in pregnancy complications and in cancer-associated thrombosis. Dr. Othman maintains an active local and international collaborative research and currently has over 75 publications in peer-reviewed journals and is an internationally recognized expert in platelet-type von Willebrand disease. She is a member of the editorial board for Seminars in Thrombosis and Hemostasis and Research Practice in Thrombosis and Haemostasis. She is a member of several scientific organizing committees and advisory boards for international haemostasis conferences and an invited speaker on topics related to PT-VWD and women’s issues in thrombosis and haemostasis. She is the current chairman of the International Society on Thrombosis and Hemostasis’s Scientific Committee (SSC) for Women’s Health Issues in Thrombosis and Hemostasis.